National Science Advisory Board for Biosecurity

Swords to Plowshares Hosts 27th Annual Veterans Day Celebration

Retrieved on: 
Tuesday, November 7, 2023
Slate, Seyfarth Shaw, Ageing, Keker, Van Nest & Peters LLP, National Science Advisory Board for Biosecurity, Wildfire, PG, Meta, Profile in Courage Award, Advisory board, Peters, Veteran, War Memorial Building (New Martinsville, West Virginia), Arnold, Quality of life, Green, Skadden, Arps, Slate, Meagher & Flom, Covington & Burling, Wells Fargo, Growth, United States Navy, LLP, Risk, Partnership, Sin, Green room, Latham & Watkins, Celebration, Ed Block Courage Award, Veterans Day, Veterans' affairs, Cooley LLP, Real estate, San Francisco Bay Area, Plowshares movement, Sword

“The Veterans Day Celebration provides an opportunity for us to reflect on our work.

Key Points: 
  • “The Veterans Day Celebration provides an opportunity for us to reflect on our work.
  • This year we have a lot to celebrate – we expanded our supportive services to target the needs of aging veterans and opened a new housing site for previously unhoused veterans,” said Michael Blecker, Executive Director of Swords to Plowshares.
  • “On this 2023 Veterans Day, we extend our gratitude to our veterans who have indispensable qualities and skills that benefit all of our communities throughout California," stated Secretary Sin, a U.S. Navy veteran.
  • This is what motivates CalVet staff every single day of the year, and we are glad to partner with Swords to Plowshares in this vital work.”
    Swords to Plowshares is proud to honor Jessie Kohgadai with this year’s Profiles of Courage Award.

AMSilk appoints Gudrun Vogtentanz as Chief Scientific Officer

Retrieved on: 
Tuesday, October 17, 2023
Health, National Science Advisory Board for Biosecurity, CSO, Protein engineering, R, Automotive Supplier Innovation Program, Big data, Protein, DSM (company), AMSilk, Advisory board, Research program, Management, Fine chemical

MUNICH, Oct. 17, 2023 /PRNewswire/ -- AMSilk GmbH ("AMSilk"), the world's first industrial supplier of bio-based performance materials, today announces the appointment of Gudrun Vogtentanz as Chief Scientific Officer (CSO).

Key Points: 
  • MUNICH, Oct. 17, 2023 /PRNewswire/ -- AMSilk GmbH ("AMSilk"), the world's first industrial supplier of bio-based performance materials, today announces the appointment of Gudrun Vogtentanz as Chief Scientific Officer (CSO).
  • Ulrich Scherbel, Chief Executive Officer of AMSilk, said: "Gudrun's skills and experience in designing proteins and accelerating time-to-market are of significant importance for AMSilk in the current scale-up phase."
  • Gudrun Vogtentanz, Chief Scientific Officer of AMSilk, added: "AMSilk's protein-based products unlock the secrets of spider silk to create engineerable structures and solutions.
  • I am excited to join AMSilk, and look forward to making a difference in sustainability while simultaneously delivering high-performance products."

AMSilk appoints Gudrun Vogtentanz as Chief Scientific Officer

Retrieved on: 
Tuesday, October 17, 2023
Health, National Science Advisory Board for Biosecurity, CSO, Protein engineering, R, Automotive Supplier Innovation Program, Big data, Protein, DSM (company), AMSilk, Advisory board, Research program, Management, Fine chemical

MUNICH, Oct. 17, 2023 /PRNewswire/ -- AMSilk GmbH ("AMSilk"), the world's first industrial supplier of bio-based performance materials, today announces the appointment of Gudrun Vogtentanz as Chief Scientific Officer (CSO).

Key Points: 
  • MUNICH, Oct. 17, 2023 /PRNewswire/ -- AMSilk GmbH ("AMSilk"), the world's first industrial supplier of bio-based performance materials, today announces the appointment of Gudrun Vogtentanz as Chief Scientific Officer (CSO).
  • Ulrich Scherbel, Chief Executive Officer of AMSilk, said: "Gudrun's skills and experience in designing proteins and accelerating time-to-market are of significant importance for AMSilk in the current scale-up phase."
  • Gudrun Vogtentanz, Chief Scientific Officer of AMSilk, added: "AMSilk's protein-based products unlock the secrets of spider silk to create engineerable structures and solutions.
  • I am excited to join AMSilk, and look forward to making a difference in sustainability while simultaneously delivering high-performance products."

Correction—Wytec Assembles Technical Experts to Advance AI Patented Technology

Retrieved on: 
Monday, August 14, 2023
RMTU, University, Senior, Internet of things, Communication, Aircraft pilot, National Science Advisory Board for Biosecurity, University of California, UCSD, Qualcomm, Attention, President Ramon Magsaysay State University, Charles Clay Trabue, Orangi Pilot Project, SAN, Artificial intelligence, City, Entrepreneurship, Electricity, Safety, Management, Science, Mathematics, Blockchain, USC, Humanities

SAN ANTONIO, TX, Aug. 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Wytec International (Wytec), a leading developer and integrator of 5G technologies, is assembling an Advisory Board to advance the development of its patented LPN-16 Small Cell technology.

Key Points: 
  • This follows Wytec’s announcement on April 28th, 2023, of a Multi-Phased Master Service Agreement with Trabus Technologies ( www.trabus.com ) to upgrade Wytec’s patented LPN-16 Small Cell ( https://wytecintl.com/technology/lpn-16-small-cell/ ) to include Artificial Intelligence (AI) and Blockchain technology.
  • The advanced integrated platform will support quick deployment of multiple IoT applications such as improved in-building cellular services, active shooter sensing technology, remote learning, and more.
  • To accelerate the Company’s technology advancements, management has appointed Robert Sanchez as the Company’s Interim CTO and a key member of the new Advisory Board.
  • To learn more about participating in Wytec's 5G Pilot Project Partnership, visit https://wytecintl.com/partner/ , or contact Wytec at [email protected] or 888-284-4531.

Wytec Assembles Technical Experts to Advance Patented Technology

Retrieved on: 
Monday, August 14, 2023
RMTU, University, Senior, Internet of things, Communication, Aircraft pilot, National Science Advisory Board for Biosecurity, University of California, UCSD, Qualcomm, Attention, President Ramon Magsaysay State University, Charles Clay Trabue, Orangi Pilot Project, SAN, Artificial intelligence, City, Entrepreneurship, Electricity, Safety, Management, Science, Mathematics, Blockchain, USC, Humanities

SAN ANTONIO, TX, Aug. 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Wytec International (Wytec), a leading developer and integrator of 5G technologies, is assembling an Advisory Board to advance the development of its patented LPN-16 Small Cell technology.

Key Points: 
  • SAN ANTONIO, TX, Aug. 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Wytec International (Wytec), a leading developer and integrator of 5G technologies, is assembling an Advisory Board to advance the development of its patented LPN-16 Small Cell technology.
  • This follows Wytec’s announcement on April 28th, 2023, of a Multi-Phased Master Service Agreement with Trabus Technologies ( www.trabus.com ) to upgrade Wytec’s patented LPN-16 Small Cell ( https://wytecintl.com/technology/lpn-16-small-cell/ ) to include Artificial Intelligence (AI) and Blockchain technology.
  • The advanced integrated platform will support quick deployment of multiple IoT applications such as improved in-building cellular services, active shooter sensing technology, remote learning, and more.
  • To learn more about participating in Wytec's 5G Pilot Project Partnership, visit https://wytecintl.com/partner/ , or contact Wytec at [email protected] or 888-284-4531.

MRES: M2Bio Sciences Appoints Adrian J. Maizey, Accomplished CEO and Financial Expert, to Advisory Board

Retrieved on: 
Wednesday, July 19, 2023
New York Stock Exchange, Treasury, Redbird, The Advisory Board Company, University, JSE Limited, Cape Epic, Investment, Service provider, Marketing, Chief financial officer, Starbucks, Biotechnology, Bachelor of Business Administration, Partner, TMT, African, AutoNation, MBA, Research, AutoZone, Friedrich Miescher Institute for Biomedical Research, Biomedical Research, Advisory board, Accounting, University of Pretoria, Business administration, National Science Advisory Board for Biosecurity, Leonard Green & Partners, Biomedicine, Secondary school, Sears Holdings, OTC, Harvard Business School, Chief, Consumer, Artificial intelligence, Science, ESL Investments, Coffee, Mental health, IBN, University of Nebraska at Kearney, ESL, Cryptocurrency, Management, Sport, Adrian

Prior to his role at Rand Capital, Adrian held several key positions in prestigious financial and investment firms, showcasing his versatile capabilities.

Key Points: 
  • Prior to his role at Rand Capital, Adrian held several key positions in prestigious financial and investment firms, showcasing his versatile capabilities.
  • Expressing his excitement about joining M2Bio Sciences' Advisory Board, Adrian Maizey said, "Joining M2Bio Sciences is invigorating.
  • Jeff Robinson, CEO of M2Bio Sciences, warmly welcomed Adrian Maizey to the Advisory Board, stating, "We are thrilled to have Adrian Maizey on board with us.
  • Adrian Maizey's appointment to the Advisory Board further reinforces M2Bio Sciences' commitment to fostering innovation and advancing transformative solutions in the biotechnology arena.

Avaya Appoints Sagi Dudai as Board Advisor to Bolster Cloud Engineering Efforts

Retrieved on: 
Monday, June 26, 2023
Software, Technology, Internet, Communication, National Science Advisory Board for Biosecurity, Mercury, Software supply chain, API, Fring, Advisory board, ARR, Engineering, Intel, Growth, Vonage, Hewlett-Packard, Avaya, Management, Ribbon Communications

Avaya LLC (“Avaya” or the “Company”), a global leader in customer experience solutions, today announced the appointment of Sagi Dudai, a seasoned product and engineering leader with expertise in large scale, SaaS Enterprise software.

Key Points: 
  • Avaya LLC (“Avaya” or the “Company”), a global leader in customer experience solutions, today announced the appointment of Sagi Dudai, a seasoned product and engineering leader with expertise in large scale, SaaS Enterprise software.
  • Sagi Dudai is known for his experience as a chief product, technology, and engineering officer, with a proven track record of success driving product and engineering teams to develop innovative, cloud-based enterprise communication solutions.
  • He currently serves as the Chief Product & Engineering Officer at JFrog (NASDAQ: FROG), an end-to-end Software Supply Chain Platform.
  • “With our focus on building a market leading customer experience platform – the Avaya Experience Platform – Sagi Dudai will bring critical skills in cloud-based software architectures and invaluable experience running distributed global engineering teams.

Stanford Pathology Chair and Expert in Alzheimer's and Parkinson's Disease Joins Enable Medicine's Scientific Advisory Board to Advance Digital Pathology Capabilities

Retrieved on: 
Wednesday, June 14, 2023
American Association of Neuropathologists, National Science Advisory Board for Biosecurity, Drug development, University, Alzheimer's disease, Stanford University, Marie Cassidy, NIA, United States Air Force Scientific Advisory Board, Intelligence, Research, Stanford University Medical Center, Advisory board, Parkinson's disease, Neuropathology, University of Washington Department of Global Health, NINDS, NIH, Medicine, National Alzheimer's Project Act, Medical device, Pathology

MENLO PARK, Calif., June 14, 2023 /PRNewswire/ -- Enable Medicine announced today that Dr. Thomas Montine has joined its Scientific Advisory Board .

Key Points: 
  • MENLO PARK, Calif., June 14, 2023 /PRNewswire/ -- Enable Medicine announced today that Dr. Thomas Montine has joined its Scientific Advisory Board .
  • Dr. Montine joins eight other leaders in the fields of artificial intelligence, drug development, and oncology on the Advisory Board.
  • Dr. Montine is the Chair of the Department of Pathology at Stanford University where he is the Stanford Medicine Endowed Professor in Pathology and is on the Board of Directors of Stanford Health Care.
  • Dr. Montine is among the top recipients of NIH funding for all Department of Pathology faculty in the United States.

Catalyst Pharmaceuticals Appoints Tamar Thompson to its Board of Directors

Retrieved on: 
Tuesday, May 30, 2023
Trident, National Science Advisory Board for Biosecurity, Catalyst Pharmaceuticals, State Government Affairs Council, Bristol Myers Squibb, Health policy, Trident University International, Government, Public health, Patient, Cypress, Alexion, Rare, CORAL, Alexion Pharmaceuticals, Compugen (company), Fine chemical, Management, Pharmaceutical industry, Science, Catalysis, D.C

CORAL GABLES, Fla., May 30, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today announced the appointment of Ms. Tamar Thompson to the Company's Board of Directors ("Board"), effective on May 25, 2023.

Key Points: 
  • CORAL GABLES, Fla., May 30, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today announced the appointment of Ms. Tamar Thompson to the Company's Board of Directors ("Board"), effective on May 25, 2023.
  • "I am honored to join the Catalyst Board at such a pivotal time in the Company’s history," said Ms. Thompson.
  • Ms. Thompson currently serves as Vice President, Head of Global Corporate Affairs for Alexion Pharmaceutical, AstraZeneca Rare Diseases.
  • Prior to joining Alexion, Ms. Thompson served as Executive Director, State Government Affairs and Federal Policy for Bristol-Myers Squibb Company.

Bloom Science Names Top Biotechnology Executive, Dr. Grace E. Colón, Board Chair

Retrieved on: 
Wednesday, May 17, 2023
Precigen, BIO, Gilead Sciences, National Science Advisory Board for Biosecurity, Central nervous system, Therapy, University, Massachusetts Institute of Technology, Health, Biotechnology, National Science Foundation, DSM-IV codes, Social entrepreneurship, Research, MIT, Genomics, Doctor of Philosophy, CNS, Exact sciences, Advisory board, Gut–brain axis, McKinsey & Company, Entrepreneurship, Santa Clara University, Patient, Biotechnology Innovation Organization, Chemical engineering, SAN, Bloom, Merck, Synthetic biology, Affymetrix, Pharmaceutical industry, Trustee

Dr. Colón has over 25 years of experience in biopharma, genomics, diagnostics, healthcare, industrial microbiology/biotechnology, synthetic biology, venture capital, management consulting, and entrepreneurship.

Key Points: 
  • Dr. Colón has over 25 years of experience in biopharma, genomics, diagnostics, healthcare, industrial microbiology/biotechnology, synthetic biology, venture capital, management consulting, and entrepreneurship.
  • She serves on the boards of CareDx, Voyager Therapeutics, the MIT Corporation (MIT's Board of Trustees) and the Biotechnology Innovation Organization (BIO), and is also Executive Chair (formerly CEO) of ProterixBio.
  • "We are thrilled to welcome Dr. Colón as the Chair of our Board of Directors," said Christopher Reyes, PhD, founder and CEO of Bloom Science.
  • "Bloom Science is the leading microbiome company dedicated to developing innovative therapies for neurological diseases through the gut-brain connection," said Dr. Colón.